Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic

Min Woo Lee1, Young Jun Kim, Hee Sun Park

  • 1Department of Radiology and Research Institute of Biomedical Science, Konkuk University School of Medicine, 4-12 Hwayang-dong, Gwangjin-gu, Seoul 143-729, South Korea.

Abstract

Insights

Targeted ultrasonography detects most small hepatocellular carcinomas (HCCs) found by CT/MRI. Tumor size and proximity to the diaphragm significantly impact HCC visibility on ultrasound, affecting early cancer detection.

Area of Science:

  • Hepatobiliary imaging
  • Diagnostic radiology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) is a common primary liver cancer.
  • Early detection of small HCCs is crucial for effective treatment.
  • CT and MRI are primary tools for HCC discovery.

Purpose of the Study:

  • To determine the detection rate of targeted ultrasonography for small HCCs (
  • To identify factors influencing the visibility of these small HCCs during targeted ultrasound examinations.

Main Methods:

  • Prospective study of cirrhotic patients with small HCCs (October 2005 - April 2008).
  • Targeted ultrasonography performed by a radiologist aware of HCC size and location.
  • Statistical analysis (univariate and multivariate) to compare visible vs. invisible HCCs based on various factors.

Main Results:

  • Overall detection rate for small HCCs (
  • Detection rates varied by size: 36.4% for <=1.0 cm, 77.6% for 1.1-2.0 cm, and 93.9% for 2.1-3.0 cm.
  • Tumor size and distance from the diaphragm were significant factors affecting sonographic visibility.

Conclusions:

  • Targeted ultrasonography is effective in detecting a majority of small HCCs.
  • Smaller tumor size and subphrenic location independently predict sonographic invisibility.
  • These findings aid in optimizing ultrasound surveillance for HCC.